# OnCo record upmc-hillman (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/upmc-hillman/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "upmc-hillman" ;
  schema:name "UPMC Hillman Cancer Center"@en ;
  schema:alternateName "University of Pittsburgh Cancer Institute"@en ;
  schema:description "UPMC Hillman is Pittsburgh's NCI comprehensive centre; Bernard Fisher ran the NSABP breast trials here, Yuan Chang and Patrick Moore discovered Kaposi sarcoma herpesvirus and Merkel cell polyomavirus, and its LAG-3 biology underpins the melanoma drug relatlimab."@en ;
  schema:url <https://onco.cc/institutions/upmc-hillman/>, <https://hillman.upmc.com> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://hillman.upmc.com>, <https://hillman.upmc.com/research/clinical-trials> ;
  schema:addressCountry "US" ;
  schema:addressLocality "Pittsburgh, PA" ;
  schema:latitude "40.455"^^xsd:decimal ;
  schema:longitude "-79.96"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/kaposi-sarcoma/>, <https://onco.cc/cancers/merkel-cell-carcinoma/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/microbiome-modulation-io/>, <https://onco.cc/technologies/gamma-knife/>, <https://onco.cc/technologies/radiosurgery-srs/>, <https://onco.cc/technologies/cyberknife/> ;
  onco:targets <https://onco.cc/targets/lag3/> ;
  onco:drugs <https://onco.cc/drugs/tamoxifen/>, <https://onco.cc/drugs/relatlimab-nivolumab/>, <https://onco.cc/drugs/cetuximab/> ;
  onco:companies <https://onco.cc/companies/nrg-oncology/> ;
  onco:people <https://onco.cc/people/jason-luke/> .
